P

Parthenon Therapeutics

31 employees

Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Life Science

Date founded

2019

Funding rounds raised

Total raised

$65M

from 5 investors over 5 rounds

P

Parthenon Therapeutics raised $65M on November 3, 2021

Investors: Section 32, Breakout Ventures, KdT Ventures, Tekla Capital Management and Northpond Ventures

FAQ